Heartbeam Inc (BEAT)

Currency in USD
0.493
+0.015(+3.14%)
Closed·
0.489-0.004(-0.87%)
·
BEAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4720.497
52 wk Range
0.4714.000
Key Statistics
Prev. Close
0.478
Open
0.473
Day's Range
0.472-0.497
52 wk Range
0.471-4
Volume
210.1K
Average Volume (3m)
737.88K
1-Year Change
-55.1818%
Book Value / Share
0.15
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BEAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.375
Upside
+584.58%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Heartbeam Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.375
(+584.58% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy2.00+305.68%-New Coverage14-07-2026
H.C. Wainwright
Buy2.50+407.10%5.50Maintain22-05-2026
Benchmark
Buy5.00+914.20%8.00Maintain15-05-2026
D. Boral Capital
Hold---Downgrade20-04-2026
B.Riley
Buy4.00+711.36%-New Coverage31-03-2026

Heartbeam Inc Earnings Call Summary for Q2/2026

  • HeartBeam reported Q2 2026 EPS of -$1.10, missing analyst estimates of -$0.09 by $1.01, representing an 1,122% variance from forecast.
  • Operating cash burn improved to $3.3M, down 7% sequentially and 3% YoY; cash balance stood at $8.8M after $11.5M April capital raise.
  • Company guided FY2026 operating cash outflow below $14M and Q4 baseline cash flow under $2.5M per quarter, extending runway into 2027.
  • Commercial launch of HeartBeam card underway with first orders shipped; FDA pre-submission completed for heart attack detection program.
  • Pivotal trial for myocardial infarction detection expected before year-end 2026 via 510(k) pathway; 25 patents issued worldwide.
Last Updated: 14-08-2026, 03:20 am
Read Full Transcript

Earnings

Latest Release
13-08-2026
EPS / Forecast
-1.10 / -0.09
Revenue / Forecast
100K / 184.25K
EPS Revisions
Last 90 days

BEAT Income Statement

Compare BEAT to Peers and Sector

Metrics to compare
BEAT
Peers
Sector
Relationship
P/E Ratio
−1.4x−1.5x−0.4x
PEG Ratio
−0.05−0.240.00
Price/Book
3.4x3.1x2.6x
Price / LTM Sales
-2.2x3.1x
Upside (Analyst Target)
-50.1%48.9%
Fair Value Upside
Unlock19.9%6.2%Unlock

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart’s electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.88M5.19%1.42M
Other Institutional Investors
9.98M17.97%4.92M
Public Companies & Retail Investors
42.65M76.84%21.04M
Total
55.51M100.00%27.38M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Strome Investment Management, L.P.6.58%36,50,0001,801
Vanguard Capital Management, LLC4.35%24,12,3301,190

FAQ

What Is the Heartbeam (BEAT) Share Price Today?

The Heartbeam share price today is 0.493.

What is the current Heartbeam (BEAT) share price and day range?

As of 23-08-2026, the Heartbeam share price is 0.493, with a previous close of 0.478. The share price has ranged from 0.472 to 0.497 today, while the 52-week range spans from 0.471 to 4.000.

What Is the Heartbeam Market Cap?

As of today, Heartbeam market cap is 27.800M.

What Is the Heartbeam (BEAT) Share Price Target?

The average 12-month share price target for Heartbeam is 3.375, with a high estimate of 5 and a low estimate of 2. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +584.58% Upside potential.

What Is Heartbeam's Earnings Per Share (TTM)?

The Heartbeam EPS (TTM) is -0.495.

When Is the Next Heartbeam Earnings Date?

Heartbeam will release its next earnings report on 05-11-2026.

From a Technical Analysis Perspective, Is BEAT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Heartbeam Trade On?

Heartbeam is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Heartbeam?

The stock symbol for Heartbeam is "BEAT."

How Many Times Has Heartbeam Stock Split?

Heartbeam has split 0 times.

How Many Employees Does Heartbeam Have?

Heartbeam has 16 employees.

What Is the BEAT Premarket Price?

BEAT's last pre-market stock price is 0.481. The pre-market share volume is 27,950.000, and the stock has changed by 0.003, or 0.630%.

What Is the BEAT After Hours Price?

BEAT's last after hours stock price is 0.489, the stock has changed by -0.004, or -0.870%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.